Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Manitoba
$27,000.00
Postsynaptic adhesion molecule NLGN1 as a trans-synaptic modulator of mGluR2 function and pharmacology
FY 2025-26
Summary
Healthy brain function relies on millions of neurons communicating in a coordinated way. This communication depends on many proteins working together at the synapse, the small gap where one neuron signals to the next. When these systems malfunction, synaptic communication becomes disrupted, contributing to conditions such as autism spectrum disorder (ASD). G protein-coupled receptors (GPCRs) are key regulators of synaptic signaling, helping neurons adjust how much chemical signal is released or received. They are so important that about one-third of FDA-approved drugs target them. Although GPCRs are well studied, recent work shows they can also be regulated by synaptic adhesion molecules, proteins that help connect and organize neurons, revealing a new and understudied layer of control in the brain. One recent discovery shows that Neuroligin-1 (NLGN1), a synaptic protein, interacts with mGluR2, a GPCR involved in controlling excitatory transmission. Both proteins have been implicated in ASD, and several Neuroligin-1 variants found in autistic individuals occur in the region that binds mGluR2. This suggests these genetic changes may alter mGluR2 function and disrupt neuronal communication. My project will investigate how typical NLGN1 and ASD-associated variants influence mGluR2 behaviour. I will examine their binding interactions, how mGluR2 traffics to and appears on the cell surface, and how effectively it signals inside the cell. Using a pharmacological cell model, I will test whether ASD-linked variants impair these processes. By clarifying how NLGN1 regulates mGluR2 and how autism-associated variants change this relationship, this research aims to uncover molecular mechanisms that may contribute to ASD and inform future therapeutic strategies targeting mGluR2.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572555
Name
Tadele Henok H
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Postsynaptic adhesion molecule NLGN1 as a trans-synaptic modulator of mGluR2 function and pharmacology
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Autism Spectrum Disorder (Asd); G Protein-Coupled Receptors (Gpcrs); Metabotropic Glutamate Receptor 2 (Mglur2); Neurodevelopmental Disorders; Neuroligin 1 (Nlgn1); Neuropsychiatric Disorders; Synaptic Adhesion Molecules (Sams)
Abstract
Healthy brain function relies on millions of neurons communicating in a coordinated way. This communication depends on many proteins working together at the synapse, the small gap where one neuron signals to the next. When these systems malfunction, synaptic communication becomes disrupted, contributing to conditions such as autism spectrum disorder (ASD). G protein-coupled receptors (GPCRs) are key regulators of synaptic signaling, helping neurons adjust how much chemical signal is released or received. They are so important that about one-third of FDA-approved drugs target them. Although GPCRs are well studied, recent work shows they can also be regulated by synaptic adhesion molecules, proteins that help connect and organize neurons, revealing a new and understudied layer of control in the brain. One recent discovery shows that Neuroligin-1 (NLGN1), a synaptic protein, interacts with mGluR2, a GPCR involved in controlling excitatory transmission. Both proteins have been implicated in ASD, and several Neuroligin-1 variants found in autistic individuals occur in the region that binds mGluR2. This suggests these genetic changes may alter mGluR2 function and disrupt neuronal communication. My project will investigate how typical NLGN1 and ASD-associated variants influence mGluR2 behaviour. I will examine their binding interactions, how mGluR2 traffics to and appears on the cell surface, and how effectively it signals inside the cell. Using a pharmacological cell model, I will test whether ASD-linked variants impair these processes. By clarifying how NLGN1 regulates mGluR2 and how autism-associated variants change this relationship, this research aims to uncover molecular mechanisms that may contribute to ASD and inform future therapeutic strategies targeting mGluR2.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tadele, Henok H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~